Target
Platelet-activating factor receptor
Ligand
BDBM50041921
Substrate
n/a
Meas. Tech.
ChEBML_155136
IC50
40±n/a nM
Citation
 Whittaker, MThompson, TMSpavold, ZMPrice, MMiller, AGalloway, WFraser, FFloyd, CDDrummond, AHDavidson, AHBowles, SABebbington, DS Cyclic ether acetal platelet activating factor (PAF) receptor antagonists I: 3-pyridyl derivatives Bioorg Med Chem Lett 3:1493-1498 (1993)    Article 
Target
Name:
Platelet-activating factor receptor
Synonyms:
PAF Platelet activating factor | PAF-R | PAFR | PTAFR | PTAFR_HUMAN | Platelet activating factor receptor | Platelet-activating factor receptor
Type:
Enzyme Catalytic Domain
Mol. Mass.:
39219.60
Organism:
Homo sapiens (Human)
Description:
PAF Platelet activating factor PTAFR HUMAN::P25105
Residue:
342
Sequence:
MEPHDSSHMDSEFRYTLFPIVYSIIFVLGVIANGYVLWVFARLYPCKKFNEIKIFMVNLTMADMLFLITLPLWIVYYQNQGNWILPKFLCNVAGCLFFINTYCSVAFLGVITYNRFQAVTRPIKTAQANTRKRGISLSLVIWVAIVGAASYFLILDSTNTVPDSAGSGNVTRCFEHYEKGSVPVLIIHIFIVFSFFLVFLIILFCNLVIIRTLLMQPVQQQRNAEVKRRALWMVCTVLAVFIICFVPHHVVQLPWTLAELGFQDSKFHQAINDAHQVTLCLLSTNCVLDPVIYCFLTKKFRKHLTEKFYSMRSSRKCSRATTDTVTEVVVPFNQIPGNSLKN
  
Inhibitor
Name:
BDBM50041921
Synonyms:
5-{4-[2-(3,4,5-Trimethoxy-phenyl)-ethyl]-phenyl}-2,3-dihydro-imidazo[2,1-a]isoquinoline | CHEMBL449395 | SDZ-64-412
Type:
Small organic molecule
Emp. Form.:
C28H28N2O3
Mol. Mass.:
440.5335
SMILES:
COc1cc(CCc2ccc(cc2)C2=Cc3ccccc3C3=NCCN23)cc(OC)c1OC |t:14,23|
Structure:
Search PDB for entries with ligand similarity: